SCHEMBL16901848

SCHEMBL16901848

CCCc1ccc2cc(C(=O)O)oc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TBXAS1 P24557 2/20 0.52
▸ LMNA P02545 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ PIM1 P11309 5/20 0.49
▸ CSNK2A1 P68400 3/20 0.49
▸ CSNK2A2 P19784 2/20 0.49
▸ CSNK2B P67870 2/20 0.49
▸ CSNK2A3 Q8NEV1 2/20 0.49
▸ NPC1 O15118 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ FLT3 P36888 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11746320 0.87 TBXAS1 (0.55) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL16901849 0.83 NPC1 (0.50) NPC1ALDH1A1POLBRAB9ASMN1; SMN2
SCHEMBL16903621 0.80 TBXAS1 (0.49) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL11487550 0.80 TBXAS1 (0.52) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL28246550 0.80 TBXAS1 (0.55) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL23512544 0.78 LMNA (0.48) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL22587927 0.78 TBXAS1 (0.50) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL29355363 0.77 ALDH1A1 (0.60) LMNAPIM1CSNK2A1CSNK2A2CSNK2B
SCHEMBL5599845 0.76 PIM1 (0.54) TBXAS1LMNATP53PIM1CSNK2A1
SCHEMBL17182687 0.76 DRD2 (0.42) TBXAS1LMNATP53NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150197512-A1 ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES PROVID PHARMACEUTICALS INC. 2015-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197512-A1 ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES FBL, POLRMT, POLR1C TBXAS1 1566/4885LMNA 514/4885TP53 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback